BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huang F, Geng XP. Chemokines and hepatocellular carcinoma. World J Gastroenterol 2010; 16(15): 1832-1836 [PMID: 20397259 DOI: 10.3748/wjg.v16.i15.1832]
URL: https://www.wjgnet.com/1007-9327/full/v16/i15/1832.htm
Number Citing Articles
1
James Sligh, Jaroslav Janda, Jana Jandova. Mutations in BALB mitochondrial DNA induce CCL20 up-regulation promoting tumorigenic phenotypesMutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2014; 769: 49 doi: 10.1016/j.mrfmmm.2014.07.003
2
Yin Xia, Linlin Zhou, Hung-Chih Yang, Chen-Wei Yu. Chemokine CCL5 immune subtypes of human liver cancer with prognostic significanceInternational Immunopharmacology 2022; 113: 109372 doi: 10.1016/j.intimp.2022.109372
3
Antonio Solinas, Diego F Calvisi. Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomasWorld Journal of Gastroenterology 2015; 21(12): 3472-3479 doi: 10.3748/wjg.v21.i12.3472
4
Lorenzo A. Orci, Stéphanie Lacotte, Graziano Oldani, Philippe Morel, Gilles Mentha, Christian Toso. The Role of Hepatic Ischemia–Reperfusion Injury and Liver Parenchymal Quality on Cancer RecurrenceDigestive Diseases and Sciences 2014; 59(9): 2058 doi: 10.1007/s10620-014-3182-7
5
Carmen Berasain, María Ujue Latasa, Raquel Urtasun, Saioa Goñi, María Elizalde, Oihane Garcia-Irigoyen, María Azcona, Jesús Prieto, Matías A. Ávila. Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver CancerCancers 2011; 3(2): 2444 doi: 10.3390/cancers3022444
6
Olaia Martínez-Iglesias, Elvira Alonso-Merino, Ana Aranda. Tumor suppressive actions of the nuclear receptor corepressor 1Pharmacological Research 2016; 108: 75 doi: 10.1016/j.phrs.2016.04.027
7
Wan Liu, Wenjing Wang, Xinran Wang, Cong Xu, Ning Zhang, Wen Di. Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axisCancer Letters 2020; 472: 59 doi: 10.1016/j.canlet.2019.12.024
8
Anupam Bishayee. Inflammation and CancerAdvances in Experimental Medicine and Biology 2014; 816: 401 doi: 10.1007/978-3-0348-0837-8_16
9
Jakub Dobroch, Klaudia Bojczuk, Adrian Kołakowski, Marta Baczewska, Paweł Knapp. The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial CancerMolecules 2022; 27(7): 2041 doi: 10.3390/molecules27072041
10
Junwei Han, Siyao Liu, Yunpeng Zhang, Yanjun Xu, Ying Jiang, Chunlong Zhang, Chunquan Li, Xia Li. MiRSEA: Discovering the pathways regulated by dysfunctional MicroRNAsOncotarget 2016; 7(34): 55012 doi: 10.18632/oncotarget.10839
11
Yidi Sun. A systematic pan-cancer analysis reveals the clinical prognosis and immunotherapy value of C-X3-C motif ligand 1 (CX3CL1)Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1183795
12
Burcu Sengez, Brian I. Carr, Hani Alotaibi. EMT and Inflammation: Crossroads in HCCJournal of Gastrointestinal Cancer 2023; 54(1): 204 doi: 10.1007/s12029-021-00801-z
13
Xinjie Lu. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in CancerCurrent Medicinal Chemistry 2022; 29(41): 6228 doi: 10.2174/0929867329666220629140540
14
Ke‐qi Han, Hui Han, Xue‐qun He, Lei Wang, Xiao‐dong Guo, Xue‐ming Zhang, Jie Chen, Quan‐gang Zhu, Hua Nian, Xiao‐feng Zhai, Ma‐wei Jiang. Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinomaCancer Medicine 2016; 5(10): 2861 doi: 10.1002/cam4.843
15
Zhitao Zhou, Xiao Lu, Ping Zhu, Wei Zhu, Xia Mu, Rongmei Qu, Ming Li. VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cellsBiochemical and Biophysical Research Communications 2012; 420(2): 336 doi: 10.1016/j.bbrc.2012.02.160
16
Xiongfeng Pan, Atipatsa C Kaminga, Shi Wu Wen, Aizhong Liu. Chemokines in hepatocellular carcinoma: a meta-analysisCarcinogenesis 2020; 41(12): 1682 doi: 10.1093/carcin/bgaa106
17
Hacer Sahin, Christian Trautwein, Hermann E. Wasmuth. Functional role of chemokines in liver disease modelsNature Reviews Gastroenterology & Hepatology 2010; 7(12): 682 doi: 10.1038/nrgastro.2010.168
18
QUANCHI CHEN, WEI SUN, YUXIN LIAO, HUI ZENG, LIANCHENG SHAN, FEI YIN, ZHUOYING WANG, ZIFEI ZHOU, YINGQI HUA, ZHENGDONG CAI. Monocyte chemotactic protein-1 promotes the proliferation and invasion of osteosarcoma cells and upregulates the expression of AKTMolecular Medicine Reports 2015; 12(1): 219 doi: 10.3892/mmr.2015.3375
19
Chunyan Li, Dong Kang, Xiguang Sun, Yufei Liu, Jinhong Wang, Pujun Gao. The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt SignalingBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/345413
20
Reza Ghasemi, Seyed H. Ghaffari, Majid Momeny, Saeed Pirouzpanah, Mehdi Yousefi, Mohsen Malehmir, Kamran Alimoghaddam, Ardeshir Ghavamzadeh. Multitargeting and Antimetastatic Potentials of Silibinin in Human HepG-2 and PLC/PRF/5 Hepatoma CellsNutrition and Cancer 2013; 65(4): 590 doi: 10.1080/01635581.2013.770043
21
Xiaolei Jiao, Guiming Shu, Hui Liu, Qin Zhang, Zhe Ma, Chaoyi Ren, Hongsheng Guo, Jingxiang Shi, Junguo Liu, Chuanshan Zhang, Yijun Wang, Yingtang Gao. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver MetastasisJournal of Histochemistry & Cytochemistry 2019; 67(5): 299 doi: 10.1369/0022155418824274
22
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical ReviewInternational Journal of Molecular Sciences 2023; 24(5): 4286 doi: 10.3390/ijms24054286
23
Wen‐Hsiu Hsu, Cheng‐Nan Chen, Hai‐I Huang, Yi‐Liang Lai, Chun‐Yuh Teng, Wu‐Hsien Kuo. Urokinase induces stromal cell‐derived factor‐1 expression in human hepatocellular carcinoma cellsJournal of Cellular Physiology 2012; 227(2): 697 doi: 10.1002/jcp.22777
24
Qiaofei Liu, Aiqun Zhang, Wenli Xu, Jiahong Dong. A new view of the roles of blood flow dynamics and Kupffer cell in intra-hepatic metastasis of hepatocellular carcinomaMedical Hypotheses 2011; 77(1): 87 doi: 10.1016/j.mehy.2011.03.033
25
Christian Breunig, Bernadett J. Mueller, Ludmila Umansky, Kristin Wahl, Katrin Hoffmann, Frank Lehner, Michael P. Manns, Heike Bantel, Christine S. Falk. BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular CarcinomaClinical Cancer Research 2014; 20(9): 2410 doi: 10.1158/1078-0432.CCR-13-1635
26
Justin Monnier, Mathieu Boissan, Annie L’Helgoualc’h, Marie-Lise Lacombe, Bruno Turlin, Jessica Zucman-Rossi, Nathalie Théret, Claire Piquet-Pellorce, Michel Samson. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cellsEuropean Journal of Cancer 2012; 48(1): 138 doi: 10.1016/j.ejca.2011.06.044
27
Jialiang Wang, Xiaoyu Zhang, Xinyi Ma, Dongmei Chen, Meina Cai, Lexin Xiao, Jing Li, Zexuan Huang, Yuehua Huang, Yifan Lian. Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research 2023; 42(1) doi: 10.1186/s13046-023-02885-w
28
Wei Qiu, Guangyi Wang, Xiaodong Sun, Junfeng Ye, Feng Wei, Xiaoju Shi, Guoyue Lv. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinomaMedical Oncology 2015; 32(3) doi: 10.1007/s12032-015-0530-1
29
Gang Han, Dawei Wu, Yongan Yang, Zhiyun Li, Jiapin Zhang, Chengjun Li. CrkL meditates CCL20/CCR6-induced EMT in gastric cancerCytokine 2015; 76(2): 163 doi: 10.1016/j.cyto.2015.05.009
30
Marie Anson, Anne-Marie Crain-Denoyelle, Véronique Baud, Fanny Chereau, Angélique Gougelet, Benoit Terris, Satoshi Yamagoe, Sabine Colnot, Mireille Viguier, Christine Perret, Jean-Pierre Couty. Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in miceJournal of Clinical Investigation 2012; 122(2): 586 doi: 10.1172/JCI43937
31
Olaia A. Martínez-Iglesias, Elvira Alonso-Merino, Sara Gómez-Rey, Juan Pedro Velasco-Martín, Rosa Martín Orozco, Enrique Luengo, Rosa García Martín, Inmaculada Ibáñez de Cáceres, Agustín F. Fernández, Mario F. Fraga, Pilar González-Peramato, Constantino Varona, José Palacios, Javier Regadera, Ana Aranda. Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasisProceedings of the National Academy of Sciences 2016; 113(3) doi: 10.1073/pnas.1520469113
32
AW Wahid Ansari, Reinhold E Schmidt, Esaki M Shankar, Adeeba Kamarulzaman. Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexusJournal of Translational Medicine 2014; 12(1) doi: 10.1186/s12967-014-0341-8
33
Bosheng He, Ying He, Weixiang Shi, Shenchu Gong, Xiaohong Chen, Jing Xiao, Jinhua Gu, Wenbin Ding, Yilang Wang. Bioinformatics analysis of gene expression alterations in microRNA-122 knockout mice with hepatocellular carcinomaMolecular Medicine Reports 2017; 15(6): 3681 doi: 10.3892/mmr.2017.6445
34
S. Costantini, G. Di Bernardo, M. Cammarota, G. Castello, G. Colonna. Gene expression signature of human HepG2 cell lineGene 2013; 518(2): 335 doi: 10.1016/j.gene.2012.12.106
35
Monika Zajkowska, Barbara Mroczko. Chemokines in Primary Liver CancerInternational Journal of Molecular Sciences 2022; 23(16): 8846 doi: 10.3390/ijms23168846
36
Stephen Fahey, Eugene Dempsey, Aideen Long. The role of chemokines in acute and chronic hepatitis C infectionCellular & Molecular Immunology 2014; 11(1): 25 doi: 10.1038/cmi.2013.37
37
Maria Neve Polimeno, Caterina Ierano, Crescenzo D'Alterio, Nunzia Simona Losito, Maria Napolitano, Luigi Portella, Giosuè Scognamiglio, Fabiana Tatangelo, Anna Maria Trotta, Steven Curley, Susan Costantini, Raffaele Liuzzi, Francesco Izzo, Stefania Scala. CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does notCellular & Molecular Immunology 2015; 12(4): 474 doi: 10.1038/cmi.2014.102
38
Xiao-Lan Wei, Jing Zhang, Zhi-Hong Mo. Regulation of chemokine receptor CXCR4 in HepG2 cell adhesion sensing by QCMProceedings 2011 International Conference on Human Health and Biomedical Engineering 2011; : 1317 doi: 10.1109/HHBE.2011.6029075
39
Siti A Sulaiman, Nadiah Abu, Nurul-Syakima Ab-Mutalib, Teck Yew Low, Rahman Jamal. Signatures of Gene Expression, DNA Methylation and microRNAs of Hepatocellular Carcinoma with Vascular InvasionFuture Oncology 2019; 15(22): 2603 doi: 10.2217/fon-2018-0909
40
Christian Stock. From Malignant Transformation to MetastasisReviews of Physiology, Biochemistry and Pharmacology 2021; 182: 139 doi: 10.1007/112_2021_68
41
Chang-Xian Li, Kwan Man, Chung-Mau Lo. The Impact of Liver Graft Injury on Cancer Recurrence PosttransplantationTransplantation 2017; 101(11): 2665 doi: 10.1097/TP.0000000000001844
42
Swathy S. Samban, Aparna Hari, Bhagyalakshmi Nair, Ayana. R. Kumar, Benjamin S. Meyer, Arun Valsan, Vinod Vijayakurup, Lekshmi R. Nath. An Insight Into the Role of Alpha-Fetoprotein (AFP) in the Development and Progression of Hepatocellular CarcinomaMolecular Biotechnology 2024; 66(10): 2697 doi: 10.1007/s12033-023-00890-0
43
Sen-Sen LIN, Fang-Fang LI, Li SUN, Wei FAN, Ming GU, Lu-Yong ZHANG, Song QIN, Sheng-Tao YUAN. Marsdenia tenacissima extract suppresses A549 cell migration through regulation of CCR5-CCL5 axis, Rho C, and phosphorylated FAKChinese Journal of Natural Medicines 2016; 14(3): 203 doi: 10.1016/S1875-5364(16)30017-6
44
Kanjoormana Aryan Manu, Muthu K. Shanmugam, Tina H. Ong, Aruljothi Subramaniam, Kodappully Sivaraman Siveen, Ekambaram Perumal, Ramar Perumal Samy, Pradeep Bist, Lina H. K. Lim, Alan Prem Kumar, Kam M. Hui, Gautam Sethi, Kwan Man. Emodin Suppresses Migration and Invasion through the Modulation of CXCR4 Expression in an Orthotopic Model of Human Hepatocellular CarcinomaPLoS ONE 2013; 8(3): e57015 doi: 10.1371/journal.pone.0057015
45
Jill Koshiol, Ilona Argirion, Zhiwei Liu, Tram Kim Lam, Thomas R. O’Brien, Kelly Yu, Katherine A. McGlynn, Jessica L. Petrick, Ligia Pinto, Chien‐jen Chen, Allan Hildesheim, Ruth M. Pfeiffer, Mei‐Hsuan Lee, Hwai‐I Yang. Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus‐ and hepatitis C virus‐infected individualsAlimentary Pharmacology & Therapeutics 2021; 54(6): 833 doi: 10.1111/apt.16524
46
Weilong Chen, Yuanyuan Qin, Suling Liu. Tumor MicroenvironmentAdvances in Experimental Medicine and Biology 2020; 1231: 53 doi: 10.1007/978-3-030-36667-4_6
47
Ken Shirabe, Takashi Motomura, Jun Muto, Takeo Toshima, Rumi Matono, Yohei Mano, Kazuki Takeishi, Hideki Ijichi, Noboru Harada, Hideaki Uchiyama, Tomoharu Yoshizumi, Akinobu Taketomi, Yoshihiko Maehara. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical managementInternational Journal of Clinical Oncology 2010; 15(6): 552 doi: 10.1007/s10147-010-0131-0
48
Franck Chiappini. Circulating Tumor Cells Measurements in Hepatocellular CarcinomaInternational Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/684802
49
Yasuteru Kondo, Osamu Kimura, Yasuhito Tanaka, Masashi Ninomiya, Tomoaki Iwata, Takayuki Kogure, Jun Inoue, Masaya Sugiyama, Tatsuki Morosawa, Yasuyuki Fujisaka, Tooru Shimosegawa, J.-H. J. Ou. Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1 + Immune Cells Journal of Virology 2015; 89(14): 7016 doi: 10.1128/JVI.00716-15
50
Feng Xue, Brandon W. Higgs, Jiaqi Huang, Chris Morehouse, Wei Zhu, Xin Yao, Philip Brohawn, Zhan Xiao, Yinong Sebastian, Zheng Liu, Yun Xia, Dong Shen, Mike Kuziora, Zhengwei Dong, Hulin Han, Yi Gu, Jianren Gu, Qiang Xia, Yihong Yao. HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinomaJournal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0743-2
51
Li Li, Jing Yan, Jing Xu, Chao-Qun Liu, Zuo-Jun Zhen, Huan-Wei Chen, Yong Ji, Zhi-Peng Wu, Jian-Yuan Hu, Limin Zheng, Wan Yee Lau, Cordula M. Stover. CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular CarcinomaPLoS ONE 2014; 9(10): e110064 doi: 10.1371/journal.pone.0110064
52
Hiroshi Miyazaki, Kazuaki Takabe, W Andrew Yeudall. Chemokines, chemokine receptors and the gastrointestinal systemWorld Journal of Gastroenterology 2013; 19(19): 2847-2863 doi: 10.3748/wjg.v19.i19.2847
53
Ho-Sung Lee, In-Hee Lee, Sang-In Park, Minho Jung, Seung Gu Yang, Tae-Wook Kwon, Dae-Yeon Lee, Bashar Saad. Investigation of Anti-Liver Cancer Activity of the Herbal Drug FDY003 Using Network PharmacologyEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/5765233
54
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami. The CCL20-CCR6 Axis in Cancer ProgressionInternational Journal of Molecular Sciences 2020; 21(15): 5186 doi: 10.3390/ijms21155186
55
Chiara Taibi, Laura Vincenzi, Gianpiero D’Offizi. Hepatocellular CarcinomaUpdates in Surgery 2023; : 19 doi: 10.1007/978-3-031-09371-5_3
56
Rim Serhal, George Hilal, George Boutros, Joseph Sidaoui, Layal Wardi, Salah Ezzeddine, Nada Alaaeddine. Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory MediatorsBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/850246